Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000118228 | SCV000312142 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000366246 | SCV000383313 | likely benign | Charlevoix-Saguenay spastic ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001517094 | SCV001725508 | benign | Spastic paraplegia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000366246 | SCV001750103 | benign | Charlevoix-Saguenay spastic ataxia | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676354 | SCV001858750 | benign | not provided | 2018-07-17 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847716 | SCV002104952 | benign | Hereditary spastic paraplegia | 2016-12-12 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676354 | SCV005219340 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000118228 | SCV000152587 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Mayo Clinic Laboratories, |
RCV000676354 | SCV000802128 | benign | not provided | 2016-02-19 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000118228 | SCV001959688 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000118228 | SCV001970309 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000366246 | SCV002086186 | benign | Charlevoix-Saguenay spastic ataxia | 2019-11-19 | no assertion criteria provided | clinical testing |